Neola Medical AB (publ) (STO:NEOLA)
Sweden · Delayed Price · Currency is SEK 0.8650
+0.0250 (2.98%)
Jun 15, 2026, 9:39 AM CET
Neola Medical AB Income Statement
Financials in millions SEK. Fiscal year is January - December.
Millions SEK. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Revenue | 8.98 | 8.28 | 10.07 | 9.78 | 9.44 | 10.38 |
Other Revenue | - | - | 0.05 | 0.04 | 0.3 | 0.74 |
| 8.98 | 8.28 | 10.12 | 9.83 | 9.74 | 11.13 | |
Revenue Growth (YoY) | 1.77% | -18.13% | 2.97% | 0.84% | -12.43% | 280.64% |
Cost of Revenue | 0.2 | 0.27 | 1.37 | 1.77 | 1.42 | 1.33 |
Gross Profit | 8.79 | 8.01 | 8.75 | 8.06 | 8.32 | 9.8 |
Selling, General & Admin | 19.39 | 17.76 | 18.23 | 16.09 | 17.64 | 16.39 |
Other Operating Expenses | -0.03 | -0.05 | -0.21 | - | 0.03 | 0.04 |
Operating Expenses | 20.77 | 19.1 | 19.55 | 17.69 | 18.44 | 16.45 |
Operating Income | -11.99 | -11.09 | -10.8 | -9.63 | -10.12 | -6.65 |
Interest & Investment Income | 0.04 | 0.07 | 0.73 | 0.61 | 0.03 | - |
Currency Exchange Gain (Loss) | - | - | - | 0 | - | - |
Other Non Operating Income (Expenses) | - | - | - | - | -0 | - |
EBT Excluding Unusual Items | -11.95 | -11.02 | -10.06 | -9.01 | -10.09 | -6.65 |
Asset Writedown | - | - | - | - | -0.27 | - |
Pretax Income | -11.95 | -11.02 | -10.06 | -9.01 | -10.35 | -6.65 |
Net Income | -11.95 | -11.02 | -10.06 | -9.01 | -10.35 | -6.65 |
Net Income to Common | -11.95 | -11.02 | -10.06 | -9.01 | -10.35 | -6.65 |
Shares Outstanding (Basic) | 78 | 77 | 70 | 56 | 26 | 14 |
Shares Outstanding (Diluted) | 78 | 77 | 70 | 56 | 26 | 14 |
Shares Change (YoY) | 11.13% | 9.27% | 25.80% | 113.90% | 86.03% | 48.67% |
EPS (Basic) | -0.15 | -0.14 | -0.14 | -0.16 | -0.40 | -0.47 |
EPS (Diluted) | -0.15 | -0.14 | -0.14 | -0.16 | -0.40 | -0.47 |
Free Cash Flow | -13.02 | -11.95 | -10.92 | -6.54 | -8.6 | -7.1 |
Free Cash Flow Per Share | -0.17 | -0.16 | -0.16 | -0.12 | -0.33 | -0.51 |
Gross Margin | 97.82% | 96.69% | 86.47% | 82.04% | 85.41% | 88.05% |
Operating Margin | -133.44% | -133.93% | -106.73% | -97.97% | -103.86% | -59.80% |
Profit Margin | -133.05% | -133.07% | -99.48% | -91.70% | -106.26% | -59.80% |
Free Cash Flow Margin | -144.92% | -144.30% | -107.90% | -66.59% | -88.27% | -63.83% |
EBITDA | -10.57 | -9.71 | -9.4 | -8.19 | -9.55 | -6.64 |
EBITDA Margin | -117.69% | -117.20% | -92.95% | -83.39% | -98.00% | -59.66% |
D&A For EBITDA | 1.42 | 1.39 | 1.39 | 1.43 | 0.57 | 0.02 |
EBIT | -11.99 | -11.09 | -10.8 | -9.63 | -10.12 | -6.65 |
EBIT Margin | -133.44% | -133.93% | -106.73% | -97.97% | -103.86% | -59.80% |
Revenue as Reported | 9.01 | 8.33 | - | - | 9.75 | 11.1 |